NeoGenomics
NEO
69 hedge funds and large institutions have $79.1M invested in NeoGenomics in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 17 closing their positions.
29% more call options, than puts
Call options by funds: $94K | Put options by funds: $73K
0% more funds holding
Funds holding: 69 → 69 (0)
0% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 17
4% less capital invested
Capital invested by funds: $82.3M → $79.1M (-$3.21M)
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
Top Sellers
NEO Hedge Fund Activity: Q2 2014 in Review
69 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2014, worth a combined $79.1M — down 3.9% from $82.3M a quarter earlier.
Fund positioning in NEO was balanced in Q2 2014: 17 funds opened new positions, 17 closed out, 19 added to existing stakes and 20 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $1.89M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.71M.
- 69 institutional investors held NeoGenomics (NEO) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $79.1M of NeoGenomics stock for Q2 2014, down 3.9% quarter-over-quarter.
- 17 funds opened new NeoGenomics positions in Q2 2014 and 17 closed out, a net change of 0 holders.
- The largest NeoGenomics buyer in Q2 2014 was First Light Asset Management, an estimated $1.89M added.
- The largest NeoGenomics seller in Q2 2014 was BlackRock Fund Advisors, an estimated $2.71M sold.
Based on aggregated 13F filings for Q2 2014.